CTXR - Chief Medical Officer at Citius Pharma Acquires Company Stock Options Worth 300000 Shares | Benzinga
Myron Czuczman, Chief Medical Officer at Citius Pharma (NASDAQ:CTXR), reported a large acquisition of company stock options on October 12, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Czuczman, Chief Medical Officer at Citius Pharma, a company in the Health Care sector, was just awarded stock options worth 300,000 shares of CTXR. The options give Czuczman the right to buy the company's stock at $0.7 per share.
Citius Pharma shares are trading down 0.01% at $0.73 at the time of this writing on Friday morning. Since the current price is $0.73, this makes Czuczman's 300,000 shares worth $219,000.